Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;105(11):4599-4607.
doi: 10.1007/s00253-021-11279-x. Epub 2021 May 27.

Directed evolution of glycosyltransferase for enhanced efficiency of avermectin glucosylation

Ha-Young Choi  1   2 , Hyun Seung Lim  2 , Kwang-Hyun Park  3 , Junheon Kim  4 , Won-Gon Kim  5   6
Affiliations

Directed evolution of glycosyltransferase for enhanced efficiency of avermectin glucosylation

Ha-Young Choi et al. Appl Microbiol Biotechnol. 2021 Jun.

Abstract

Avermectin, produced by Streptomyces avermitilis, is an active compound protective against nematodes, insects, and mites. However, its potential usage is limited by its low aqueous solubility. The uridine diphosphate (UDP)-glycosyltransferase (BLC) from Bacillus licheniformis synthesizes avermectin glycosides with improved water solubility and in vitro antinematodal activity. However, enzymatic glycosylation of avermectin by BLC is limited due to the low conversion rate of this reaction. Thus, improving BLC enzyme activity is necessary for mass production of avermectin glycosides for field application. In this study, the catalytic activity of BLC toward avermectin was enhanced via directed evolution. Three mutants from the BLC mutant library (R57H, V227A, and D252V) had specific glucosylation activity for avermectin 2.0-, 1.8-, and 1.5-fold higher, respectively, than wild-type BLC. Generation of combined mutations via site-directed mutagenesis led to even further enhancement of activity. The triple mutant, R57H/V227A/D252V, had the highest activity, 2.8-fold higher than that of wild-type BLC. The catalytic efficiencies (Kcat/Km) of the best mutant (R57H/V227A/D252V) toward the substrates avermectin and UDP-glucose were improved by 2.71- and 2.29-fold, respectively, compared to those of wild-type BLC. Structural modeling analysis revealed that the free energy of the mutants was - 1.1 to - 7.1 kcal/mol lower than that of wild-type BLC, which was correlated with their improved activity. KEY POINTS: • Directed evolution improved the glucosylation activity of BLC toward avermectin. • Combinatorial site-directed mutagenesis led to further enhanced activity. • The mutants exhibited lower free energy values than wild-type BLC.

Keywords: Antinematodal; Avermectin glucoside; Directed evolution; Glycosyltransferase.

PubMed Disclaimer

References

    1. Ahn BC, Kim BG, Jeon YM, Lee EJ, Lim Y, Ahn JH (2009) Formation of flavone di-O-glucosides using a glycosyltransferase from Bacillus cereus. J Microbiol Biotechnol 19(4):387–390 - DOI
    1. Bolam DN, Roberts S, Proctor MR, Turkenburg JP, Dodson EJ, Martinez-Fleites C, Yang M, Davis BG, Davies GJ, Gilbert HJ (2007) The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity. Proc Natl Acad Sci U S A 104(13):5336–5341. https://doi.org/10.1073/pnas.0607897104 - DOI - PubMed - PMC
    1. Bowles D, Lim EK, Poppenberger B, Vaistij FE (2006) Glycosyltransferases of lipophilic small molecules. Annu Rev Plant Biol 57:567–597. https://doi.org/10.1146/annurev.arplant.57.032905.105429 - DOI - PubMed
    1. Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong Y-L, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, Ōmura S (1979) Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 15(3):361–367 - DOI
    1. Buss O, Rudat J, Ochsenreither K (2018) FoldX as protein engineering tool: better than random based approaches? Comput Struct Biotechnol J 16:25–33. https://doi.org/10.1016/j.csbj.2018.01.002 - DOI - PubMed - PMC

MeSH terms

Supplementary concepts

LinkOut - more resources